Safety and Efficacy of Two Types of Botulinum Toxin Type A For the Treatment of Glabellar Lines

PHASE4CompletedINTERVENTIONAL

Enrollment

224

Participants

Timeline

Start Date

September 30, 2010

Primary Completion Date

January 31, 2011

Study Completion Date

April 30, 2011

Conditions

Glabellar Lines

Interventions

BIOLOGICAL

botulinum toxin type A

20 units (total dose) botulinum toxin type A injected into glabellar region on Day 0

BIOLOGICAL

botulinum toxin type A

30 units (total dose) botulinum toxin type A injected into glabellar region on Day 0

Trial Locations (1)

Munich